Showing results (731-740 of 900) with videos related to
Sort By:
Pageof 90
JACC. Clinical Electrophysiology|June 12, 2026
Life-Threatening Delayed Myocardial Ischemia, Ventricular Arrhythmias, and SCD After PFA of AF: An Extended Case SeriesMelanie A Gunawardene, Boris Schmidt, Petr Neuzil, et al.Plos Medicine|April 19, 2017
Effectiveness of a live oral human rotavirus vaccine after programmatic introduction in Bangladesh: A cluster-randomized trialK Zaman, David A Sack, Kathleen M Neuzil, et al.Circulation|May 26, 2026
Pulsed Field Ablation Versus Sham to Treat Atrial Fibrillation: The PFA-SHAM Randomized Clinical TrialPavel Osmancik, Petr Neuzil, Jana Hozmanova, et al.American Heart Journal|December 17, 2016
Interventional left atrial appendage closure vs novel anticoagulation agents in patients with atrial fibrillation indicated for long-term anticoagulation (PRAGUE-17 study)Pavel Osmancik, Petr Tousek, Dalibor Herman, et al.Vaccine|April 24, 2012
Methodology and lessons-learned from the efficacy clinical trial of the pentavalent rotavirus vaccine in BangladeshK Zaman, M Yunus, Shams El Arifeen, et al.Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|September 2, 2015
The learning curve associated with the introduction of the subcutaneous implantable defibrillatorReinoud E Knops, Tom F Brouwer, Craig S Barr, et al.Annals of Internal Medicine|May 5, 2010
Safety of herpes zoster vaccine in the shingles prevention study: a randomized trialMichael S Simberkoff, Robert D Arbeit, Gary R Johnson, et al.Heart Rhythm|March 8, 2017
Initial international multicenter human experience with a novel epicardial access needle embedded with a real-time pressure/frequency monitoring to facilitate epicardial access: Feasibility and safetyLuigi Di Biase, J David Burkhardt, Vivek Reddy, et al.The Lancet. Infectious Diseases|August 19, 2018
Safety and immunogenicity of a pentavalent meningococcal conjugate vaccine containing serogroups A, C, Y, W, and X in healthy adults: a phase 1, single-centre, double-blind, randomised, controlled studyWilbur H Chen, Kathleen M Neuzil, C Rebecca Boyce, et al.Heart Rhythm|March 14, 2020
Real-world experience of leadless left ventricular endocardial cardiac resynchronization therapy: A multicenter international registry of the WiSE-CRT pacing systemBenjamin J Sieniewicz, Timothy R Betts, Simon James, et al.Pageof 90